Most exudative retinal diseases are chronic and relapsing, and while treatable with anti-vascular endothelial growth factor (VEGF) medications, they require repeated therapeutic interventions over years, often indefinitely. The gene discussed is VEGFA; the disease is Abnormal retinal morphology.